Drug Profile
Research programme: tubulin polymerisation inhibitors - Eisai
Alternative Names: ER 68378; ER 68384; ER-68394Latest Information Update: 24 May 2010
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class
- Mechanism of Action Tubulin polymerisation inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 08 Feb 2007 Preclinical trials in Cancer in India (unspecified route)